ALZHEIMER'S DRUG DISCOVERY FOUNDATION (ADDF) STATEMENT ON FDA'S TRADITIONAL APPROVAL OF KISUNLA (DONANEMAB)

Press/Media

Period	2 Jul 2024

Media coverage

Title	ALZHEIMER'S DRUG DISCOVERY FOUNDATION (ADDF) STATEMENT ON FDA'S TRADITIONAL APPROVAL OF KISUNLA (DONANEMAB)
Media name/outlet	The Shippensburg News-Chronicle
Country/Territory	United States
Date	2/07/24
URL	ct.moreover.com/?a=54205132666&p=1gw&v=1&x=yTJ8NrEsEyhtow9XREt00g
Persons	Howard Fillit